The Opioid Overdose Resuscitation Education for Addiction Counselors and Trainees (Opioid Overdose REACT) naloxone response education pilot project improved confidence and knowledge among addiction counselors and trainees

References

• SAMHSA.gov [Internet]. Rockville, MD: Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration; [cited 2022 Aug 12]. Available from https://www.samhsa.gov/data.
   Google Scholar
• Kariisa M, Davis NL, Kumar S, et al. Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics—25 states and the District Of Columbia, 2019–2020. MMWR Morb Mortal Wkly Rep. 2022;71(29):940–947. doi: 10.15585/mmwr.mm7129e2.
   PubMed Web of Science ®Google Scholar
• Wermeling DP. A response to the opioid overdose epidemic: naloxone nasal spray. Drug Deliv Transl Res. 2013;3(1):63–74. doi: 10.1007/s13346-012-0092-0.
   PubMed Web of Science ®Google Scholar
• Loimer N, Hofmann P, Chaudhry HR. Nasal administration of naloxone is as effective as the intravenous route in opiate addicts. Int J Addict. 1994;29(6):819–827. doi: 10.3109/10826089409047912.
   PubMed Web of Science ®Google Scholar
• Barton ED, Colwell CB, Wolfe T, et al. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting. J Emerg Med. 2005;29(3):265–271. doi: 10.1016/j.jemermed.2005.03.007.
   PubMed Web of Science ®Google Scholar
• Robertson TM, Hendey GW, Stroh G, et al. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose. Prehosp Emerg Care. 2009;13(4):512–515. doi: 10.1080/10903120903144866.
   PubMed Web of Science ®Google Scholar
• Kelly AM, Kerr D, Koutsogiannis Z, et al. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. Med J Aust. 2005;182(1):24–27. doi: 10.5694/j.1326-5377.2005.tb06550.x.
   PubMed Web of Science ®Google Scholar
• Merlin MA, Saybolt M, Kapitanyan R, et al. Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses. Am J Emerg Med. 2010;28(3):296–303. doi: 10.1016/j.ajem.2008.12.009.
   PubMed Web of Science ®Google Scholar
• Doe-Simkins M, Walley AY, Epstein A, et al. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health. 2009;99(5):788–791. doi: 10.2105/AJPH.2008.146647.
   PubMed Web of Science ®Google Scholar
• Dwyer K, Walley AY, Langlois BK, et al. Opioid education and nasal naloxone rescue kits in the emergency department. West J Emerg Med. 2015;16(3):381–384. doi: 10.5811/westjem.2015.2.24909.
   PubMed Web of Science ®Google Scholar
• Fisher R, O’Donnell D, Ray B, et al. Police officers can safely and effectively administer intranasal naloxone. Prehosp Emerg Care. 2016;20(6):675–680. doi: 10.1080/10903127.2016.1182605.
   PubMed Web of Science ®Google Scholar
• Rando J, Broering D, Olson JE, et al. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths. Am J Emerg Med. 2015;33(9):1201–1204. doi: 10.1016/j.ajem.2015.05.022.
   PubMed Web of Science ®Google Scholar
• Giglio RE, Li G, DiMaggio CJ. Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis. Inj Epidemiol. 2015;2(1):1–9. doi: 10.1186/s40621-015-0041-8.
   PubMedGoogle Scholar
• Goldberg SA, Dworkis DA, Liao VT, et al. Feasibility of bystander administration of public-access naloxone for opioid overdose. Prehosp Emerg Care. 2018;22(6):788–794. doi: 10.1080/10903127.2018.1461284.
   PubMed Web of Science ®Google Scholar
• Eggleston W, Calleo V, Kim M, et al. Naloxone administration by untrained community members. Pharmacotherapy. 2020;40(1):84–88. doi: 10.1002/phar.2352.
   PubMed Web of Science ®Google Scholar
• Bazazi AR, Zaller ND, Fu JJ, et al. Preventing opiate overdose deaths: examining objections to take-home naloxone. J Health Care Poor Underserved. 2010;21(4):1108–1113. doi: 10.1353/hpu.2010.0935.
   PubMed Web of Science ®Google Scholar
• Freeman PR, Hankosky ER, Lofwall MR, et al. The changing landscape of naloxone availability in the United States, 2011–2017. Drug Alcohol Depend. 2018;191:361–364. doi: 10.1016/j.drugalcdep.2018.07.017.
   PubMed Web of Science ®Google Scholar
• Kirane H, Ketteringham M, Bereket S, et al. Awareness and attitudes toward intranasal naloxone rescue for opioid overdose prevention. J Subst Abuse Treat. 2016;69:44–49. doi: 10.1016/j.jsat.2016.07.005.
   PubMed Web of Science ®Google Scholar
• Green TC, Case P, Fiske H, et al. Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states. J Am Pharm Assoc. 2017;57(2S):S19–S27.e4. doi: 10.1016/j.japh.2017.01.013.
   Google Scholar
• Bessen S, Metcalf SA, Saunders EC, et al. Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA. Int J Drug Policy. 2019;74:144–151. doi: 10.1016/j.drugpo.2019.09.008.
   PubMed Web of Science ®Google Scholar
• Bakhireva LN, Bautista A, Cano S, et al. Barriers and facilitators to dispensing of intranasal naloxone by pharmacists. Subst Abus. 2018;39(3):331–341. doi: 10.1080/08897077.2017.1391924.
   PubMed Web of Science ®Google Scholar
• Thakur T, Frey M, Chewning B. Pharmacist roles, training, and perceived barriers in naloxone dispensing: a systematic review. J Am Pharm Assoc. 2020;60(1):178–194. doi: 10.1016/j.japh.2019.06.016.
   Google Scholar
• Lai RK, Friedson KE, Reveles KR, et al. Naloxone accessibility without an outside prescription from US community pharmacies: a systematic review. J Am Pharm Assoc. 2022;62(6):1725–1740.
   Google Scholar
• Kim HS, Aks SE. Take-home naloxone and the need for a publicly funded naloxone supply. J Addict Med. 2022;16(1):1–3. doi: 10.1097/ADM.0000000000000821.
   PubMed Web of Science ®Google Scholar
• Razaghizad A, Windle SB, Filion KB, et al. The effect of overdose education and naloxone distribution: an umbrella review of systematic reviews. Am J Public Health. 2021;111(8):e1–e12. doi: 10.2105/AJPH.2021.306306.
   PubMedGoogle Scholar
• Tobin K, Clyde C, Davey-Rothwell M, et al. Awareness and access to naloxone necessary but not sufficient: examining gaps in the naloxone Cascade. Int J Drug Policy. 2018;59:94–97. doi: 10.1016/j.drugpo.2018.07.003.
   PubMed Web of Science ®Google Scholar
• Lai JT, Goldfine CE, Chapman BP, et al. Nobody wants to be Narcan’d: a pilot qualitative analysis of drug users’ perspectives on naloxone. West J Emerg Med. 2021;22(2):339.
   PubMed Web of Science ®Google Scholar
• Burn SM. Appeal to bystander interventions: a normative approach to health and risk messaging. In: Parrott R, editor. Oxford research encyclopedia of health and risk message design and processing. Oxford (UK): Oxford University Press; 2017. p. 140–155.
   Google Scholar
• Wickens CD. Designing for stress. Hum Perf Extrem Environ. 2000;5(1):11.
   Google Scholar
• Nicholson TP, Blazer EC, Hymes AS, et al. A qualitative investigation into the trauma exhibited by first responders impacted by the opioid epidemic. Int J Ment Health Addict. 2023;2023:1–22.
   Google Scholar
• Food and Drug Administration. Joint nonprescription drug advisory committee and anesthetic and analgesic drug products advisory committee meeting. Silver Spring (MD): Food and Drug Administration; 2023. (FDA Briefing Document).
   Google Scholar
• Tippey KG, Yovanoff M, McGrath LS, et al. Comparative human factors evaluation of two nasal naloxone administration devices: NARCAN® nasal spray and naloxone prefilled syringe with nasal atomizer. PainTher. 2019;8(1):89–98.
   Google Scholar
• Bauer MS, Kirchner J. Implementation science: What is it and why should I care? Psychiatry Res. 2020;283:112376. doi: 10.1016/j.psychres.2019.04.025.
   PubMed Web of Science ®Google Scholar
• Thomas A, Bussières A. Leveraging knowledge translation and implementation science in the pursuit of evidence informed health professions education. Adv Health Sci Educ Theory Pract. 2021;26(3):1157–1171. doi: 10.1007/s10459-020-10021-y.
   PubMed Web of Science ®Google Scholar
• Wensing M, Grol R. Knowledge translation in health: How implementation science could contribute more. BMC Med. 2019;17(1):1–6. doi: 10.1186/s12916-019-1322-9.
   PubMedGoogle Scholar
• Crabb AC, Linton JM. A qualitative study of recovering and nonrecovering substance abuse counselors’ belief systems. J Addict Offender Couns. 2007;28(1):4–20. doi: 10.1002/j.2161-1874.2007.tb00028.x.
   Google Scholar
• Culbreth JR. Substance abuse counselors with and without a personal history of chemical dependency: a review of the literature. Alcohol Treat Q. 2000;18(2):67–82. doi: 10.1300/J020v18n02_05.
   Google Scholar
• Hagedorn WB, Culbreth JR, Cashwell CS. Addiction counseling accreditation: CACREP’s role in solidifying the counseling profession. TPC. 2012;2(2):124–133. doi: 10.15241/wbh.2.2.124.
   Google Scholar
• Stanley JS. Education level, recovery status, and 12 step adherence: surveying substance use disorder counselors opiate replacement preferences [dissertation]. Minneapolis (MN): Capella University; 2021.
   Google Scholar
• Abraham AJ, Ducharme LJ, Roman PM. Counselor attitudes toward pharmacotherapies for alcohol dependence. J Stud Alcohol Drugs. 2009;70(4):628–635. doi: 10.15288/jsad.2009.70.628.
   PubMed Web of Science ®Google Scholar
• Miller G, Scarborough J, Clark C, et al. The need for national credentialing standards for addiction counselors. J Addict Offender Couns. 2010;30(2):50–57. doi: 10.1002/j.2161-1874.2010.tb00056.x.
   Google Scholar
• Kerr D, Dietze P, Kelly AM. Intranasal naloxone for the treatment of suspected heroin overdose. Addiction. 2008;103(3):379–386. doi: 10.1111/j.1360-0443.2007.02097.x.
   PubMed Web of Science ®Google Scholar
• Urmanche AA. Bearing witness to the epidemic: supporting clinicians after a client overdose death. Pract Innov. 2020;5(4):275–289. doi: 10.1037/pri0000115.
   Google Scholar
• Sperandio KR, Goshorn JR, Moh YS, et al. Never ready: addictions counselors dealing with client death. J Counsel Develop. 2023;101(1):29–45. doi: 10.1002/jcad.12440.
   Web of Science ®Google Scholar
• Zuckerman M, Weisberg SN, Boyer EW. Pitfalls of intranasal naloxone. Prehosp Emerg Care. 2014;18(4):550–554. doi: 10.3109/10903127.2014.896961.
   PubMed Web of Science ®Google Scholar
• Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367(2):146–155. doi: 10.1056/NEJMra1202561.
   PubMed Web of Science ®Google Scholar
• DATAUSA.io [Internet]. Cambridge, MA: Substance Abuse and Behavioral Disorder Counselors; [cited 2022 Dec 21]. Available from: https://datausa.io/profile/soc/substance-abuse-and-behavioral-disorder-counselors.
   Google Scholar
• Williams AV, Strang J, Marsden J. Development of opioid overdose knowledge (OOKS) and attitudes (OOAS) scales for take-home naloxone training evaluation. Drug Alcohol Depend. 2013;132(1–2):383–386. doi: 10.1016/j.drugalcdep.2013.02.007.
   PubMed Web of Science ®Google Scholar